AR026227A1 - PHARMACEUTICAL COMPOSITIONS CONTAINING AN ANTIBIOTIC DRUG OF FLUOROQUINOLONE AND XANTANO GUM - Google Patents
PHARMACEUTICAL COMPOSITIONS CONTAINING AN ANTIBIOTIC DRUG OF FLUOROQUINOLONE AND XANTANO GUMInfo
- Publication number
- AR026227A1 AR026227A1 ARP000105597A ARP000105597A AR026227A1 AR 026227 A1 AR026227 A1 AR 026227A1 AR P000105597 A ARP000105597 A AR P000105597A AR P000105597 A ARP000105597 A AR P000105597A AR 026227 A1 AR026227 A1 AR 026227A1
- Authority
- AR
- Argentina
- Prior art keywords
- fluoroquinolone
- pharmaceutical compositions
- compositions containing
- gum
- xantano
- Prior art date
Links
- 230000003115 biocidal effect Effects 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title abstract 2
- 229940124307 fluoroquinolone Drugs 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000003242 anti bacterial agent Substances 0.000 title 1
- 229920001285 xanthan gum Polymers 0.000 abstract 1
- 229940082509 xanthan gum Drugs 0.000 abstract 1
- 235000010493 xanthan gum Nutrition 0.000 abstract 1
- 239000000230 xanthan gum Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Se describen composiciones farmacéuticas que contiene una droga antibiotico de fluoroquinolona y a la goma de xantano compatibles.Pharmaceutical compositions containing a compatible antibiotic drug of fluoroquinolone and compatible xanthan gum are described.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16269399P | 1999-11-01 | 1999-11-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR026227A1 true AR026227A1 (en) | 2003-01-29 |
Family
ID=22586735
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000105597A AR026227A1 (en) | 1999-11-01 | 2000-10-24 | PHARMACEUTICAL COMPOSITIONS CONTAINING AN ANTIBIOTIC DRUG OF FLUOROQUINOLONE AND XANTANO GUM |
Country Status (19)
Country | Link |
---|---|
US (1) | US6331540B1 (en) |
EP (1) | EP1225898B1 (en) |
JP (1) | JP2003513046A (en) |
KR (1) | KR20020048967A (en) |
CN (1) | CN1384745A (en) |
AR (1) | AR026227A1 (en) |
AT (1) | ATE243038T1 (en) |
AU (1) | AU8008300A (en) |
BR (1) | BR0015256A (en) |
CA (1) | CA2386822A1 (en) |
DE (1) | DE60003445T2 (en) |
DK (1) | DK1225898T3 (en) |
ES (1) | ES2199873T3 (en) |
HK (1) | HK1045940A1 (en) |
MX (1) | MXPA02004349A (en) |
PL (1) | PL354928A1 (en) |
PT (1) | PT1225898E (en) |
TR (1) | TR200201174T2 (en) |
WO (1) | WO2001032181A2 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050009922A1 (en) * | 2001-01-27 | 2005-01-13 | Carlson Paul E. | Stable aqueous antimicrobial suspension |
ES2388170T3 (en) * | 2001-08-24 | 2012-10-09 | Uvic Industry Partnerships Inc. | Proaerolysin containing protease activation sequences and methods of use for the treatment of prostate cancer |
CN1293880C (en) | 2002-07-31 | 2007-01-10 | 千寿制药株式会社 | Aqueous liquid preparations and light-stabilized aqueous liquid preparations |
US8877168B1 (en) | 2002-07-31 | 2014-11-04 | Senju Pharmaceuticals Co., Ltd. | Aqueous liquid preparations and light-stabilized aqueous liquid preparations |
US8524734B2 (en) | 2005-05-18 | 2013-09-03 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
AU2006247053B2 (en) * | 2005-05-18 | 2013-05-23 | Horizon Therapeutics U.S. Holding Llc | Aerosolized fluoroquinolones and uses thereof |
BRPI0719776A2 (en) * | 2006-10-12 | 2014-04-22 | Kyorin Seiyaku Kk | WATER LIQUID PREPARATION HAVING IMPROVED INTRAOCULAR GATIFLOXACIN PENETRATION |
JP4578576B2 (en) * | 2008-03-31 | 2010-11-10 | 杏林製薬株式会社 | Gatifloxacin-containing aqueous solution |
EP2260848A4 (en) * | 2008-03-31 | 2013-02-13 | Kyorin Seiyaku Kk | Aqueous liquid containing gatifloxacin, method for production thereof, and method for prevention of production of precipitates during storage of the aqueous liquid at low temperature or upon freezing/thawing of the aqueous liquid |
TWI544934B (en) * | 2008-06-09 | 2016-08-11 | 愛爾康研究有限公司 | Improved pharmaceutical compositions containing a fluoroquinolone antibiotic drug |
BRPI0920026B1 (en) | 2008-10-07 | 2023-11-07 | Horizon Orphan Llc | PHARMACEUTICAL COMPOSITION AND RESPECTIVE USES |
DK2346509T3 (en) | 2008-10-07 | 2020-08-03 | Horizon Orphan Llc | INHALATION OF LEVOFLOXACIN TO REDUCE POULTRY INFLAMMATION |
IN2012DN02477A (en) | 2009-09-04 | 2015-08-21 | Mpex Pharmaceuticals Inc | |
EP2540307B1 (en) * | 2010-02-24 | 2016-05-25 | Morinaga Milk Industry Co., Ltd. | Antibacterial auxiliary agent comprising kombu extract as active ingredient, antibacterial composition, and food or beverage |
US9050357B2 (en) * | 2010-03-08 | 2015-06-09 | Cp Kelco U.S., Inc. | Compositions and methods for producing consumables for patients with dysphagia |
GR1008168B (en) | 2013-03-14 | 2014-04-08 | "Φαρματεν Α.Β.Ε.Ε.", | Parenteral formulation of fluoroquinolone antibacterial agent and method for preparation thereof |
JP6602534B2 (en) * | 2013-09-27 | 2019-11-06 | 三栄源エフ・エフ・アイ株式会社 | Liquid thickener |
JP6538322B2 (en) * | 2013-09-27 | 2019-07-03 | 三栄源エフ・エフ・アイ株式会社 | Liquid toning agent |
JP6713728B2 (en) * | 2015-05-01 | 2020-06-24 | 三栄源エフ・エフ・アイ株式会社 | Liquid thickener |
IL271777B2 (en) | 2017-07-07 | 2024-09-01 | Epicentrx Inc | Compositions for parenteral administration of therapeutic agents |
US11382910B2 (en) | 2020-08-26 | 2022-07-12 | Somerset Therapeutics, Llc. | Loteprednol and moxifloxacin compositions and methods |
US11298315B2 (en) | 2020-08-26 | 2022-04-12 | Somerset Therapeutics, Llc. | Triamcinolone and moxifloxacin compositions |
US11484538B2 (en) | 2020-08-26 | 2022-11-01 | Somerset Therapeutics, Llc | Bromfenac, prednisolone, and moxifloxacin compositions and methods |
Family Cites Families (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3700451A (en) | 1970-04-06 | 1972-10-24 | Itek Corp | Gelable and gelled compositions |
US3944427A (en) | 1970-04-06 | 1976-03-16 | Itek Corporation | Gelable and gelled compositions |
US3784712A (en) | 1970-12-23 | 1974-01-08 | Gen Foods Corp | Gum gelling system xanthan-tara dessert gel |
CA1070629A (en) | 1975-11-10 | 1980-01-29 | Allen I. Laskin | Process for modifying biopolymers |
US4135979A (en) | 1976-08-24 | 1979-01-23 | Merck & Co., Inc. | Treatment of xanthan gum to improve clarity |
US4136173A (en) | 1977-01-31 | 1979-01-23 | American Home Products Corp. | Mixed xanthan gum and locust beam gum therapeutic compositions |
US4136177A (en) | 1977-01-31 | 1979-01-23 | American Home Products Corp. | Xanthan gum therapeutic compositions |
US4136178A (en) | 1977-01-31 | 1979-01-23 | American Home Products Corp. | Locust bean gum therapeutic compositions |
GB8318403D0 (en) | 1983-07-07 | 1983-08-10 | Sutherland I W | Gel-forming polysaccharides |
FR2551087B1 (en) | 1983-08-30 | 1986-03-21 | Rhone Poulenc Spec Chim | PROCESS FOR TREATING POLYSACCHARIDE SOLUTION AND USE THEREOF |
DE3335593A1 (en) | 1983-09-30 | 1985-04-11 | Diamalt AG, 8000 München | GELLING AND THICKENING AGENT BASED ON CASSIA GALACTOMANNANS |
US4717713A (en) | 1983-10-31 | 1988-01-05 | Research Corporation | Controlled release liquid pharmaceutical |
US4708861A (en) | 1984-02-15 | 1987-11-24 | The Liposome Company, Inc. | Liposome-gel compositions |
FR2588189B1 (en) | 1985-10-03 | 1988-12-02 | Merck Sharp & Dohme | LIQUID-GEL PHASE TRANSITION PHARMACEUTICAL COMPOSITION |
US4647470A (en) | 1985-11-27 | 1987-03-03 | Merck & Co., Inc. | Low-acetyl gellan gum blends |
FR2618333B1 (en) | 1987-07-20 | 1990-07-13 | Merck Sharp & Dohme | PHARMACEUTICAL AND / OR COSMETIC COMPOSITION FOR TOPICAL USE CONTAINING RHAMSAM GUM |
US5192535A (en) | 1988-02-08 | 1993-03-09 | Insite Vision Incorporated | Ophthalmic suspensions |
US4814160A (en) | 1988-03-01 | 1989-03-21 | Colgate-Palmolive Company | Non-bleeding striped dentifrice |
US5234957A (en) | 1991-02-27 | 1993-08-10 | Noven Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
US5446070A (en) | 1991-02-27 | 1995-08-29 | Nover Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
DE3843416A1 (en) | 1988-12-23 | 1990-06-28 | Wolff Walsrode Ag | XANTHAN WITH IMPROVED SOLUBILITY AND METHOD FOR PRODUCTION |
CA2021414C (en) | 1989-07-25 | 2004-09-28 | Daniel H. Doherty | Genetic control of acetylation and pyruvylation of xanthan gum |
US5461081A (en) | 1989-09-28 | 1995-10-24 | Alcon Laboratories, Inc. | Topical ophthalmic pharmaceutical vehicles |
FR2653021A1 (en) | 1989-10-17 | 1991-04-19 | Merck Sharp & Dohme | AQUEOUS LIQUID OPHTHALMIC COMPOSITION WITH LIQUID-GEL PHASE TRANSITION. |
DK0495421T3 (en) | 1991-01-15 | 1996-12-09 | Alcon Lab Inc | Use of carrageenans in topical ophthalmic compositions |
US5212162A (en) | 1991-03-27 | 1993-05-18 | Alcon Laboratories, Inc. | Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions |
DK0604570T3 (en) | 1991-09-17 | 1998-09-14 | Alcon Lab Inc | Preparations containing quinolone antibiotics and polystyrene sulfonate |
US5192802A (en) | 1991-09-25 | 1993-03-09 | Mcneil-Ppc, Inc. | Bioadhesive pharmaceutical carrier |
US5318780A (en) | 1991-10-30 | 1994-06-07 | Mediventures Inc. | Medical uses of in situ formed gels |
US5473062A (en) | 1992-10-29 | 1995-12-05 | Takeda Chemical Industries, Ltd. | Process for producing purified xanthan gum |
JP3228315B2 (en) | 1993-04-23 | 2001-11-12 | 信越化学工業株式会社 | Method for reducing the viable count of xanthan gum |
ES2068762B1 (en) * | 1993-07-21 | 1995-12-01 | Lipotec Sa | A NEW PHARMACEUTICAL PREPARATION TO IMPROVE THE BIOAVAILABILITY OF DRUGS OF DIFFICULT ABSORPTION AND PROCEDURE FOR THEIR OBTAINING. |
JPH09510961A (en) | 1994-01-14 | 1997-11-04 | ジュニア シャヒニアン,リー | Methods of persistent and long-term corneal analgesia |
US5422116A (en) | 1994-02-18 | 1995-06-06 | Ciba-Geigy Corporation | Liquid ophthalmic sustained release delivery system |
JP4259610B2 (en) | 1994-04-08 | 2009-04-30 | キューエルティー・ユーエスエイ・インコーポレーテッド | Liquid delivery composition |
US5523301A (en) | 1994-08-05 | 1996-06-04 | Merck & Co., Inc. | Optic nerve health |
CN1162148C (en) | 1994-08-30 | 2004-08-18 | 阿尔康实验室公司 | Thermally-gelling ophthalmic drug delivery vehicles containing cellulose ethers |
US5972326A (en) | 1995-04-18 | 1999-10-26 | Galin; Miles A. | Controlled release of pharmaceuticals in the anterior chamber of the eye |
FR2742336B1 (en) | 1995-12-19 | 1998-03-06 | Chauvin Lab Sa | EYE DROPS INTENDED IN PARTICULAR FOR TREATING EYE DRY |
SE9603480L (en) | 1996-09-23 | 1998-03-24 | Johan Carlfors | Dosage form for hard soluble drugs |
FR2754712B1 (en) | 1996-10-17 | 1999-09-03 | Merck Sharp Dohme Chibret Lab | OPHTHALMIC COMPOSITIONS |
US5888493A (en) | 1996-12-05 | 1999-03-30 | Sawaya; Assad S. | Ophthalmic aqueous gel formulation and related methods |
CA2291777A1 (en) | 1997-05-30 | 1998-12-03 | Merck & Co., Inc. | Ophthalmic compositions for treating ocular hypertension |
CA2294343A1 (en) | 1997-06-26 | 1999-01-07 | Merck & Co., Inc. | Method for optimizing retinal and optic nerve health |
DE69808790T3 (en) * | 1997-09-12 | 2009-07-16 | The Procter & Gamble Co., Cincinnati | SKIN CLEANSING AND CONDITIONING ITEMS FOR SKIN AND HAIR |
KR100598722B1 (en) * | 1998-04-07 | 2006-07-11 | 알콘 래보레이토리스, 인코퍼레이티드 | Gelling ophthalmic compositions containing xanthan gum |
US6166012A (en) * | 1999-07-30 | 2000-12-26 | Allergan Sales, Inc. | Antibiotic compositions and method for using same |
-
2000
- 2000-10-10 WO PCT/US2000/028031 patent/WO2001032181A2/en active IP Right Grant
- 2000-10-10 DE DE60003445T patent/DE60003445T2/en not_active Expired - Lifetime
- 2000-10-10 BR BR0015256-0A patent/BR0015256A/en not_active Application Discontinuation
- 2000-10-10 US US09/686,083 patent/US6331540B1/en not_active Expired - Lifetime
- 2000-10-10 CN CN00815003A patent/CN1384745A/en active Pending
- 2000-10-10 AT AT00970752T patent/ATE243038T1/en active
- 2000-10-10 MX MXPA02004349A patent/MXPA02004349A/en not_active Application Discontinuation
- 2000-10-10 KR KR1020027004809A patent/KR20020048967A/en not_active Application Discontinuation
- 2000-10-10 DK DK00970752T patent/DK1225898T3/en active
- 2000-10-10 TR TR2002/01174T patent/TR200201174T2/en unknown
- 2000-10-10 PT PT00970752T patent/PT1225898E/en unknown
- 2000-10-10 PL PL00354928A patent/PL354928A1/en unknown
- 2000-10-10 ES ES00970752T patent/ES2199873T3/en not_active Expired - Lifetime
- 2000-10-10 JP JP2001534386A patent/JP2003513046A/en not_active Withdrawn
- 2000-10-10 CA CA002386822A patent/CA2386822A1/en not_active Abandoned
- 2000-10-10 EP EP00970752A patent/EP1225898B1/en not_active Expired - Lifetime
- 2000-10-10 AU AU80083/00A patent/AU8008300A/en not_active Abandoned
- 2000-10-24 AR ARP000105597A patent/AR026227A1/en unknown
-
2002
- 2002-10-07 HK HK02107339.3A patent/HK1045940A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2003513046A (en) | 2003-04-08 |
WO2001032181A3 (en) | 2002-05-02 |
BR0015256A (en) | 2002-06-18 |
US6331540B1 (en) | 2001-12-18 |
TR200201174T2 (en) | 2002-08-21 |
DE60003445T2 (en) | 2003-12-24 |
PL354928A1 (en) | 2004-03-22 |
HK1045940A1 (en) | 2002-12-20 |
WO2001032181A2 (en) | 2001-05-10 |
DE60003445D1 (en) | 2003-07-24 |
ES2199873T3 (en) | 2004-03-01 |
MXPA02004349A (en) | 2003-09-22 |
EP1225898B1 (en) | 2003-06-18 |
CN1384745A (en) | 2002-12-11 |
CA2386822A1 (en) | 2001-05-10 |
PT1225898E (en) | 2003-10-31 |
AU8008300A (en) | 2001-05-14 |
EP1225898A2 (en) | 2002-07-31 |
DK1225898T3 (en) | 2003-09-15 |
KR20020048967A (en) | 2002-06-24 |
ATE243038T1 (en) | 2003-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR026227A1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING AN ANTIBIOTIC DRUG OF FLUOROQUINOLONE AND XANTANO GUM | |
BR9810495A (en) | Pharmaceutical composition | |
AP1954A (en) | Controlled release compositions comprising nimesulide. | |
EE200200357A (en) | Pharmaceutical compositions providing increased concentrations of the drug substance | |
NO20024891D0 (en) | Pharmaceutical compositions | |
FR2764889B1 (en) | NOVEL 2- (IMINOMETHYL) AMINO-PHENYL DERIVATIVES, THEIR PREPARATION, THEIR USE AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
DE10084671T1 (en) | Pharmaceutical compositions | |
DE69900561D1 (en) | Pharmaceutical compositions containing mupirocin | |
DOP2001000199A (en) | QUINOLONA ANTIBIOTICS DELAY PREPARATIONS AND PROCEDURE FOR MANUFACTURING. | |
EE200200075A (en) | Pharmaceutical compositions for oral and topical administration | |
AR021934A1 (en) | COMPOSITION OF ORAL ADMINISTRATION WITH CONTROLLED RELEASE OF AT LEAST ONE ANALGESIC | |
DE10084344T1 (en) | Pharmaceutical composition containing cyclosporin | |
ES2172182T3 (en) | PHARMACEUTICAL COMPOSITIONS THAT INCLUDE AXETIL CEFUROXIMA. | |
BR0206960A (en) | Oral pharmaceutical composition and use of a hydroxypropyl methylcellulose phthalate polymer | |
ATE350064T1 (en) | PHARMACEUTICAL COMPOSITIONS OF RAPAMYCINES | |
AU2001260089A1 (en) | Pharmaceutical compositions comprising desglymidodrine as an active drug substance | |
HN2000000057A (en) | DERIVATIVES OF I - TRIFLUOROMETIL-4-HIDROXI-7-PIPERIDINIL- AMINOMETILCROMANO. | |
MY141008A (en) | Oral formulations of deoxypeganine and their uses | |
AU2002212863A1 (en) | Stable pharmaceutical form of an anticancer drug | |
ATE301469T1 (en) | PHARMACEUTICAL DICLOFENAC COMPOUND BASED ON VITAMIN E, PAPAIN AND HYALURONIDASE | |
AU5063700A (en) | S-nitroso- and s-nitro-n-acyl-l-cysteine-ester-derivatives as pharmacological substances and medicaments containing said compounds | |
AU2502301A (en) | Medicament and combination of compatible medicaments | |
AU1584800A (en) | Immuno-active, anti-cancer and pharmacologically active polysaccharide compoundsand pharmaceutical compositions containing the polysaccharide compounds | |
AU2676600A (en) | Pharmaceutical composition for balanic transmucosal administration of alfuzosin | |
DE50006408D1 (en) | PHARMACEUTICAL PREPARATION CONTAINING DITHRANOL |